Main content

"Impressive" new treatment for blood cancers

Genetically engineered immune cells had a success rate of more than 90%. Professor John Gribben is Chair of Medical Oncology at Barts hospital in London.

(Photo: A close up image of a lung x-ray of a cigarette smoker in an undated photo. Credit: Getty Images.)

Release date:

Duration:

3 minutes